Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5772)
All Articles published online
|
Publishing Process of This Article
|
Apr 14, 2013 (publication date) through Feb 9, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | D’Angelo S, Secondulfo M, De Cristofano R, Sorrentino P. Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma? World J Gastroenterol 2013; 19(14): 2141-2143 [PMID: 23599639 DOI: 10.3748/wjg.v19.i14.2141] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v19/i14/2141.htm |
| Number | Citing Articles |
| 1 |
Jiang Chen, Renan Jin, Jie Zhao, Jinghua Liu, Hanning Ying, Han Yan, Senjun Zhou, Yuelong Liang, Diyu Huang, Xiao Liang, Hong Yu, Hui Lin, Xiujun Cai. Potential molecular, cellular and microenvironmental mechanism of sorafenib resistance in hepatocellular carcinoma. Cancer Letters 2015; 367(1): 1 doi: 10.1016/j.canlet.2015.06.019
|
| 2 |
Zhao-Han Zhang, Yunxiang Du, Shuzhen Wei, Weidong Pei. Multilayered insights: a machine learning approach for personalized prognostic assessment in hepatocellular carcinoma. Frontiers in Oncology 2024; 13 doi: 10.3389/fonc.2023.1327147
|
| 3 |
Rodolfo Sacco, Gennaro Gadaleta-Caldarola, Giovanni Galati, Giuseppe Lombardi, GianCarlo Mazza, Giuseppe Cabibbo. European Association for the Study of the Liver Hepatocellular Carcinoma Summit 2014: Old Questions, New (or Few) Answers?. Future Oncology 2014; 10(10): 1719 doi: 10.2217/fon.14.102
|
| 4 |
Weiwei Tang, Ziyi Chen, Wenling Zhang, Ye Cheng, Betty Zhang, Fan Wu, Qian Wang, Shouju Wang, Dawei Rong, F. P. Reiter, E. N. De Toni, Xuehao Wang. The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects. Signal Transduction and Targeted Therapy 2020; 5(1) doi: 10.1038/s41392-020-0187-x
|